Diurnal is committed to transparency in its interactions. Diurnal commits to following the Association of British Pharmaceutical Industry (ABPI) Code of Practice which has clear requirements for transparency. Diurnal has published details of its transfers of value required under the ABPI Code on the ABPI website and below. Diurnal has gone beyond the requirements of the ABPI code by publishing all of its transfers of value worldwide.

Where individual countries have other transparency regulations, Diurnal also complies with the EFPIA through this route.

Diurnal is committed to transparency in clinical trials and publishes the protocols and results of its clinical trials on the website www.clinicaltrials.gov

Diurnal Group plc (Company Number: 09846650) is registered in England & Wales. Registered office: Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, UK.